Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 33711 - reverse shoulder prosthesis - composed of tial6v4 alloy, tin coated. connects to humerus head and articulates with glenosphere. humerus inverse cap component used in the mutars system as part of a shoulder replacement with the inverse option in case of rotator cuff insufficiencies. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis.

Australia - English - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 33702 - uncoated elbow humerus prosthesis - replacement of elbow joint.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 48088 - humeral head prosthesis - constructed of tial6v4 with tin coating. the modular humerus caps are available in three different sizes and allow an optimal glenoid contact. connects to a humerus head component as part of the modular universal tumor and revision system (mutars) and articulates with the glenoid. humerus cap component of the mutars system used as part of a humeral replacement. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 48088 - humeral head prosthesis - humeral head replacement prosthesis. composed of tial6v4. connects to a humerus cap and extension piece as part of a proximal or total humeral replacement in a modular universal tumor and revision system (mutars). a component of the mutars system intended to replace the humeral head as part of a proximal or total humerus reconstruction. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis.

Australia - English - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 33702 - uncoated elbow humerus prosthesis - a device used as a replacement of part of an elbow joint.

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - orthopaedics - it is intended for fixation of fractures, osteotomies, and non-unions of the, humerus, particularly in osteopenic bone.

Australia - English - Department of Health (Therapeutic Goods Administration)

naton medical aus pty ltd - 56644 - humerus nail, non-sterile - intramedullary nailing systems are composed of interlocking nails, locking bolts, locking screws, blades, lag screws, condylar screws, condylar nuts and end caps. intramedullary nailing systems are intended to be used for temporary fixation and stabilization of long bones in various anatomical regions. this is a single-use device intended to be sterilized prior to use.

Australia - English - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 58750 - elbow humerus trial prosthesis - a surgical instrument intended for use during elbow arthroplasty to evaluate the patient?s joint surface anatomy following bone preparation and facilitate the physician?s determination of approximate implant size for the corresponding joint replacement component.

Australia - English - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 38153 - fixation device, internal, nail, intramedullary, humerus - the devices are non-active implants intended to provide temporary stabilization for bones or bone fragments

Australia - English - Department of Health (Therapeutic Goods Administration)

numerus biology pty ltd - nicotinamide riboside chloride, quantity: 75 mg (equivalent: ribose, qty 38.78 mg); levomefolate calcium, quantity: 50 microgram (equivalent: levomefolic acid, qty 46.1 microgram); cyanocobalamin, quantity: 300 ng; camellia sinensis, quantity: 50 mg (equivalent: camellia sinensis, qty 500 mg; equivalent: caffeine, qty 1 mg); cysteine, quantity: 100 mg; resveratrol, quantity: 37.5 mg; quercetin, quantity: 62.5 mg; berberis aristata, quantity: 25 mg (equivalent: berberis aristata, qty 1.75 g); astragalus membranaceus, quantity: 37.5 mg (equivalent: astragalus membranaceus, qty 112.5 mg); ubidecarenone, quantity: 18.75 mg - capsule, hard - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; magnesium stearate; hypromellose; purified water; calcium carbonate; colloidal anhydrous silica - antioxidant/reduce free radicals formed in the body ; maintain/support energy levels ; maintain/support energy production ; maintain/support body mucous membrane health ; maintain/support general health and wellbeing ; aid/assist healthy red blood cell production ; maintain/support blood health ; maintain/support immune system health ; maintain/support healthy immune system function ; aid/assist/helps protein synthesis in the body ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral) within normal range ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system health ; maintain/support nervous system function ; maintain/support skin health